Case Report
 
A huge, pedunculated, multiseptated, cystic myoma misdiagnosed as an ovarian cancer in imaging studies
Chul Min Park1, Sung Yob Kim1
1Department of Obstetrics and Gynecology, Medical School of Jeju National University, Korea.

Article ID: Z01201608CR10682CP
doi:10.5348/ijcri-201694-CR-10682

Address correspondence to:
Chul Min Park
Jeju National University Hospital, Aran 13gil 15 (Ara-1Dong) Jeju city
Jeju Self-Governing Province
Korea (63241)

Access full text article on other devices

  Access PDF of article on other devices

[HTML Abstract]   [PDF Full Text] [Print This Article]
[Similar article in Pumed] [Similar article in Google Scholar]


How to cite this article
Park CM, Kim SY. A huge, pedunculated, multiseptated, cystic myoma misdiagnosed as an ovarian cancer in imaging studies. Int J Case Rep Images 2016;7(8):533–536.


Abstract
Introduction: A huge, pedunculated, multiseptated, cystic pelvic mass with normal uterus may cause misinterpretation of the computed tomography (CT) scan, magnetic resonance imaging (MRI) scan and PET-CT as a malignant ovarian epithelial tumor.
Case Report: A 56-year-old multipara woman complained of lower abdominal pain, abdominal distension and she consulted to local hospital. Cancer antigen 125 (CA-125) was 59.6 U/mL and the CT, MRI and PET-CT revealed that a large multiseptated cystic mass (20 cm) with soft tissue parts, multiple hemorrhage and fluid-fluid levels and that the uterus was normal finding with some ascites. Those images suggested that it might be a malignant ovarian epithelial tumor with hemorrhage. We performed an exploratory laparotomy with suspicion of ovarian malignancy and found out that the pedunculated mass was originated from the uterine fundus and that the ovaries were normal. There was a small amount of serous ascites.
Conclusion: In this study, it is suggested that clinicians carrying out differential diagnosis of pelvic mass with increasing serum CA-125 level and ascites should consider not only ovarian cancer but also myoma with cystic degeneration.

Keywords: Cystic mass, Cystic myoma, Ovary malignancy, Ovarian cancer


Introduction

In 1909, the first case of uterine myoma with ascites and hydrothorax was mentioned by Kelly et al. [1] and then Meigs reported that Meigs syndrome is characterized by the presence of benign solid ovarian tumors like fibroma associated with ascites and pleural effusion [2]. Other pelvic tumors such as teratoma, uterine myoma than fibroma associated with ascites and pleural effusion was reported as pseudo-Meigs syndrome [3].

The CA-125 (carbohydrate antigen 125, cancer antigen 125, or carcinoma antigen 125) is a type of cell surface antigens present in more than 80% of non-mucinous epithelial ovarian cancers. The CA-125 occurs in the serum of healthy females at low concentration (<35 IU/mL), however, the concentration appears to be moderately elevated in patients with several benign conditions such as uterine myoma, adenomyosis, and endometriosis [4].

We report an uncommon case of huge, pedunculated, multiseptated, cystic myoma with ascites and high serum CA-125 level (59.6 U/mL) resembling ovarian cancer.


Case Report

A 56-year-old multipara woman complained of lower abdominal pain, abdominal distension and she consulted to local hospital. She had an ultrasonography and serum CA-125 test. It revealed that 16x10 cm size, large inhomogeneous mass with some ascites and CA-125 was 59.6 U/mL. She was referred to our hospital under the impression of ovarian cancer. There was nothing remarkable in her medical history until then.

The CT scan and MRI scan revealed that a large multiseptated cystic mass (20 cm) with soft tissue parts, multiple hemorrhage and fluid-fluid levels and that the uterus was normal finding. Those images suggested that it might be a malignant ovarian epithelial tumor with hemorrhage (Figure 1). The PET-CT scan showed that large mass with mild, heterogeneous FDG uptake (SUV max 3.5) and metabolic defects in right abdomen and there is no significant abnormal FDG uptake to suggest metastatic lymph node or distant metastasis.

We performed an exploratory laparotomy with suspicion of ovarian malignancy. During the operation, we found out that the pedunculated mass was originated from the uterine fundus and that the ovaries were normal (Figure 2).

There was a small amount of serous ascites. So, we resected the mass, which was 20x18x8 cm in size and 1.593 g in weight, and the face of the mass showed cystic degeneration and multiple hemorrhagic lesion (Figure 3). The pathology confirmed leiomyoma with hemorrhage and no evidence of malignancy (Figure 4).


Cursor on image to zoom/Click text to open image
Figure 1: Computed tomography scan showed a large multiseptated cystic mass (20 cm) with soft tissue parts, multiple hemorrhage and fluid-fluid levels and uterus was normal.



Cursor on image to zoom/Click text to open image
Figure 2: Pedunculated mass was originated from the uterine fundus and the ovaries were normal.



Cursor on image to zoom/Click text to open image
Figure 3: The face of the resected mass showed cystic degeneration and multiple hemorrhagic lesion.



Cursor on image to zoom/Click text to open image
Figure 4: The pathology confirmed leiomyoma with cystic degeneration, hemorrhage and no evidence of malignancy.



Discussion

A solid pelvic mass with ascites and elevated CA-125 level almost means malignant tumor with poor prognosis for patient. But Meigs and pseudo-Meigs syndrome are well-known as benign solid ovarian mass, less commonly uterine myoma, with high CA-125, ascites and pleural effusion [1][2][3]. Therefore, we report an uncommon case of huge, pedunculated, multiseptated, cystic myoma with ascites and high serum CA-125 level (59.6 U/mL) resembling ovarian cancer.

The mechanism of the generation of ascites in benign disease like uterine myoma is unclear. Meigs suggested that the ascites may originates from edematous fibromas, which can leak fluid [3].

In case of uterine myoma, a discrepancy between an excessive arterial supply to a large tumor and limited venous and lymphatic drainage might contribute to stromal edema and cystic degeneration with subsequent transudation into the peritoneal cavity [5]. Fluid leakage probably might result from a marked cystic degeneration and intratumoral pressure [6]. Especially in case of pedunculated myoma like our case, twisting of the pedicle of the tumor and its torsion resulting in fluid production has been suggested [7]. And the subserosal location like pedunculated myoma with cystic degeneration might facilitate leakage of fluid into the abdominal cavity [5].

Another theory of ascites in myoma is that cytokines, such as vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF), and inflammatory cytokines(IL-1b, IL-6, IL-8) play roles in the development of ascites [8][9]. The mechanical irritation in peritoneum from the tumor might cause peritoneal fluid production through a process of peritoneal inflammation [10]. Probably, both a leakage of intratumoral fluid and peritoneal inflammation could contribute to the production of ascites in pedunculated myoma with cystic degeneration like our case.

And peritoneal inflammation might be the primary cause of the elevated CA-125. The associated inflammatory reaction of mesothelial cells of peritoneum is probably the very important contributor to the very high serum level of CA-125 [11].

Lee et al. commented that giant multiseptated pyomyoma simulating an ovarian cancer showed mild FDG uptake in PET-CT and CA-125 level (59.2 U/mL) less than 500 U/mL as our case. Therefore, If PET-CT show mild FDG uptake and CA-125 level is less than 500 U/mL, although other imaging studies and clinical sign suggest ovarian malignancy, I think we could suspect myoma more than ovarian malignancy [12].


Conclusion

We should not rule out the possibility of the uterine mass in the pelvic mass with intact uterus on imaging studies like our case. Especially, gynecologists should always be aware of the possibility of uterine myoma, because that is one of the most common tumors of the female pelvic organ. Therefore, all clinicians carrying out differential diagnosis of pelvic mass with increasing serum CA-125 level and ascites should consider not only ovarian cancer but also huge, pedunculated, multiseptated, cystic myoma.


References
  1. Williamson JG, Patel D, Menzies DN. Leiomyomata of the uterus associated with ascites and hydrothorax. J Obstet Gynaecol Br Commonw 1972 Mar;79(3):273–80.   [CrossRef]   [Pubmed]    Back to citation no. 1
  2. Meigs JV. Fibroma of the ovary with ascites and hydrothorax; Meigs' syndrome. Am J Obstet Gynecol 1954 May;67(5):962–85.   [CrossRef]   [Pubmed]    Back to citation no. 2
  3. Meigs JV. Pelvic tumors other than fibromas of the ovary with ascites and hydrothorax. Obstet Gynecol 1954 May;3(5):471–86.   [CrossRef]   [Pubmed]    Back to citation no. 3
  4. Bast RC Jr, Badgwell D, Lu Z, et al. New tumor markers: CA125 and beyond. Int J Gynecol Cancer 2005 Nov-Dec;15 Suppl 3:274–81.   [CrossRef]   [Pubmed]    Back to citation no. 4
  5. Amant F, Gabriel C, Timmerman D, Vergote I. Pseudo-Meigs' syndrome caused by a hydropic degenerating uterine leiomyoma with elevated CA 125. Gynecol Oncol 2001 Oct;83(1):153–7.   [CrossRef]   [Pubmed]    Back to citation no. 5
  6. Clement PB. Pure mesenchymal tumors. In: Clement PB, Young RH, eds. Tumors and tumor like lesions of the uterine corpus and cervix. New York: Churchill Livingstone; 1993. p. 265–328.   [CrossRef]   [Pubmed]    Back to citation no. 6
  7. Kempers RD, Dockerty MB, Hoffman DL, Bartholomew LG. Struma ovarii--ascitic, hyperthyroid, and asymptomatic syndromes. Ann Intern Med 1970 Jun;72(6):883–93.   [CrossRef]   [Pubmed]    Back to citation no. 7
  8. Abramov Y, Anteby SO, Fasouliotis SJ, Barak V. Markedly elevated levels of vascular endothelial growth factor, fibroblast growth factor, and interleukin 6 in Meigs syndrome. Am J Obstet Gynecol 2001 Feb;184(3):354–5.   [CrossRef]   [Pubmed]    Back to citation no. 8
  9. Abramov Y, Anteby SO, Fasouliotis SJ, Barak V. The role of inflammatory cytokines in Meigs' syndrome. Obstet Gynecol 2002 May;99(5 Pt 2):917–9.   [CrossRef]   [Pubmed]   Back to citation no. 9
  10. Jimerson SD. Pseudo-Meigs's syndrome. An unusual case with analysis of the effusions. Obstet Gynecol 1973 Oct;42(4):535–7.   [Pubmed]    Back to citation no. 10
  11. Zeimet AG, Marth C, Offner FA, et al. Human peritoneal mesothelial cells are more potent than ovarian cancer cells in producing tumor marker CA-125. Gynecol Oncol 1996 Sep;62(3):384–9.   [CrossRef]   [Pubmed]    Back to citation no. 11
  12. Lee SR, Kim BS, Moon HS. Magnetic resonance imaging and positron emission tomography of a giant multiseptated pyomyoma simulating an ovarian cancer. Fertil Steril 2010 Oct;94(5):1900–2.   [CrossRef]   [Pubmed]    Back to citation no. 12

[HTML Abstract]   [PDF Full Text]

Author Contributions
Chul Min Park – Substantial contributions to conception and design, Acquisition of data, Analysis and interpretation of data, Drafting the article, Revising it critically for important intellectual content, Final approval of the version to be published
Sung Yob Kim – Analysis and interpretation of data, Revising it critically for important intellectual content, Final approval of the version to be published
Guarantor of submission
The corresponding author is the guarantor of submission.
Source of support
None
Conflict of interest
Authors declare no conflict of interest.
Copyright
© 2016 Chul Min Park et al. This article is distributed under the terms of Creative Commons Attribution License which permits unrestricted use, distribution and reproduction in any medium provided the original author(s) and original publisher are properly credited. Please see the copyright policy on the journal website for more information.



About The Authors

Chul Min Park is Professor at OBs & GYn Department, Jeju national university hospital, Jeju, Korea. His research interests include gynecologic oncology, urogynecology and endometriosis.



Sung Yob Kim is Head Professor at OBs & GYn Department, Jeju national university hospital, Jeju, Korea. His research interests include gynecologic oncology, urogynecology and leiomyoma.